BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11727316)

  • 1. Computational methods to predict drug safety liabilities.
    Durham SK; Pearl GM
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):110-5. PubMed ID: 11727316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational methods to estimate drug development parameters.
    Podlogar BL; Muegge I; Brice LJ
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):102-9. PubMed ID: 11727315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational toxicology--a tool for early safety evaluation.
    Merlot C
    Drug Discov Today; 2010 Jan; 15(1-2):16-22. PubMed ID: 19835978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products.
    Kruhlak NL; Contrera JF; Benz RD; Matthews EJ
    Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated decision support for assessing chemical liabilities.
    Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
    J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
    Kramer JA; Sagartz JE; Morris DL
    Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structural feature-based computational approach for toxicology predictions.
    Valerio LG; Yang C; Arvidson KB; Kruhlak NL
    Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):505-18. PubMed ID: 20074001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-dimensional QSAR in drug discovery.
    Lill MA
    Drug Discov Today; 2007 Dec; 12(23-24):1013-7. PubMed ID: 18061879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational methods for the prediction of drug toxicity.
    Cronin MT
    Curr Opin Drug Discov Devel; 2000 May; 3(3):292-7. PubMed ID: 19649861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The challenge of predicting drug toxicity in silico.
    Vedani A; Dobler M; Lill MA
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):195-208. PubMed ID: 16930291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The many roles of computation in drug discovery.
    Jorgensen WL
    Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
    La Motta C; Sartini S; Tuccinardi T; Nerini E; Da Settimo F; Martinelli A
    J Med Chem; 2009 Feb; 52(4):964-75. PubMed ID: 19170633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of in vitro safety studies.
    Suter W
    Curr Opin Chem Biol; 2006 Aug; 10(4):362-6. PubMed ID: 16815733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.